Cannabis and Your Health: What Does the Science Actually Say?

Cannabis is everywhere.

It is legal for medical or recreational use in many states. CBD products are sold in wellness stores and online. Cannabis is increasingly discussed as a treatment for anxiety, pain, sleep problems, and other health concerns. At the same time, researchers continue to find potential risks to mental health, cognition, heart health, and behavior.

So which is it?

Is cannabis helpful, harmful, or somewhere in between?

The answer, based on current research, is: it depends.

The effects of cannabis vary based on the product, the amount and type of cannabinoid (different chemical compounds in the plant), how it is used, how often it is used, the person’s age and health, and what outcome we are talking about. And this distinction matters:

Cannabis is not the same thing as CBD. CBD is not the same thing as THC. A prescription cannabinoid medication is not the same thing as a cannabis product purchased at a dispensary, smoke shop, or online.

The research becomes much easier to understand once we separate these things.

First, what exactly are we talking about?

Cannabis contains hundreds of chemical compounds, including more than 100 known cannabinoids. The two most familiar are THC (tetrahydrocannabinol) and CBD (cannabidiol).

THC

THC is the cannabinoid primarily responsible for the intoxicating “high.” It can affect memory, attention, coordination, perception, mood, reaction time, and decision-making.

There are several forms of THC. The most familiar is delta-9 THC (Δ9-THC), the primary intoxicating cannabinoid in traditional cannabis.

CBD

CBD is another cannabinoid found in cannabis. Unlike THC, CBD does not produce the same intoxicating “high.”²

CBD has received enormous attention for anxiety, sleep, pain, inflammation, recovery, and general wellness. Some of these uses are promising. Many are still being studied, and there are not yet strong conclusions about effectiveness for most of these common wellness claims.

Delta-8 THC

Delta-8 THC (Δ8-THC) is a chemically related form of THC. It can produce intoxicating effects, although its effects are generally described as less potent than delta-9 THC.

Delta-8 has become widely available in products such as gummies, vapes, and other edibles. However, the FDA has not evaluated or approved delta-8 THC products for safe use and has raised concerns about adverse events, manufacturing processes, contamination, labeling, and products being marketed in ways that may put consumers at risk.³

Although delta-8 THC occurs naturally in cannabis in very small amounts, the concentrated delta-8 THC found in many commercial products is typically produced by chemically converting hemp-derived CBD. This process raises additional questions about manufacturing, contaminants, product consistency, and what is actually in the product.³

This is important because “hemp-derived” does not automatically mean “non-intoxicating” or “risk-free.”

What does the evidence actually support?

Let’s start with the good news.

There are legitimate medical uses for cannabinoids. But the strongest evidence is not that cannabis is a cure-all. Instead, certain cannabinoid medications can provide benefits for specific medical conditions.

1. Certain seizure disorders: one of the clearest examples

One of the most important discoveries in cannabinoid medicine has been the effect of purified CBD on certain severe seizure disorders.

Research led to FDA approval of Epidiolex, a prescription oral solution containing purified cannabidiol. Epidiolex is approved for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients 1 year of age and older.⁴

This is real evidence of a medical benefit from a cannabis-derived compound.

But notice what the evidence does not say. It does not say that smoking cannabis treats epilepsy, that a CBD gummy purchased online is equivalent to Epidiolex, or that THC treats seizures.

The clinical trials used a purified, standardized pharmaceutical product at controlled doses.

This is an important lesson that applies throughout cannabis research:

Evidence for a specific cannabinoid medication does not automatically establish evidence for every cannabis product containing that cannabinoid.

2. Nausea and vomiting from chemotherapy

There is also established medical use for cannabinoid-based medications in treating chemotherapy-related nausea and vomiting.

Two FDA-approved medications are particularly relevant. Dronabinol contains synthetic delta-9 THC and is approved for nausea and vomiting associated with cancer chemotherapy. It is also approved for appetite and weight loss associated with AIDS. Nabilone is a synthetic cannabinoid with a chemical structure similar to THC and is approved for chemotherapy-related nausea and vomiting when other treatments have not worked.⁵

These medications provide another important example of why saying “cannabis has no medical value” is inaccurate.

The reverse statement is also inaccurate: cannabis and its different forms have not been shown to be effective treatments for every condition for which they are marketed.

3. Some chronic pain

Cannabinoid medications may provide small improvements in chronic pain for some people. Recent systematic reviews have generally found that the benefits are modest and are accompanied by increased side effects such as dizziness, sedation, and nausea.⁶

This is an important distinction. If a treatment reduces someone’s pain a little but also causes significant cognitive or physical side effects, the question becomes whether the benefit outweighs the cost for that particular person.

That is clinical decision-making, not a simple “works” or “doesn’t work.”

4. Some symptoms associated with multiple sclerosis

Certain cannabinoid medications can help with symptoms such as spasticity in people with multiple sclerosis. Again, the evidence is stronger for specific cannabinoid preparations than for cannabis as a general treatment.¹

So yes, there are legitimate medical applications for cannabinoids. The question is not whether they have any medical value. The more useful question is where the evidence is strong, where it is promising, and where the evidence simply isn’t there yet.

What about mental health?

This is where the conversation gets particularly interesting.

Cannabis is frequently used by people who are trying to manage anxiety, depression, PTSD, stress, or sleep problems. Many people genuinely report that cannabis helps them feel calmer or temporarily takes the edge off.

But feeling better in the moment can be a form of coping; it does not necessarily mean the underlying condition is being treated.

A major 2026 systematic review published in The Lancet Psychiatry examined 54 randomized controlled trials involving 2,477 participants and evaluated cannabinoids for mental disorders and substance use disorders. The authors concluded that there was little evidence that cannabinoids are effective treatments for most mental disorders.⁷

There were some potentially promising findings, including low-quality evidence for improvements in certain symptoms associated with insomnia, cannabis use disorder, tic disorders, and autism spectrum disorder. However, the overall quality of evidence was generally low, and cannabinoids were associated with a greater risk of adverse events.⁷

For most psychiatric conditions, we simply do not have strong enough evidence to recommend cannabis as a treatment.

What about anxiety?

This is one of the questions I hear most often, and the answer is complicated.

THC can produce relaxation in some people and anxiety, panic, or paranoia in others. The experience can also change depending on the dose and the person’s individual sensitivity.

A person might say, “Cannabis helps my anxiety.”

That experience is real. But it does not necessarily tell us whether cannabis is improving the underlying anxiety disorder.

In fact, higher doses of THC can increase anxiety, fear, paranoia, and disorientation.¹

For some people, this can create a cycle of diminishing returns and adverse effects:

Anxiety → cannabis → temporary relief → tolerance → more cannabis → anxiety returns → cannabis again.

That pattern does not happen to everyone. But when cannabis becomes the primary strategy for managing uncomfortable emotions, it is worth asking whether it is helping the person build long-term coping skills or simply providing short-term relief.

What about depression and PTSD?

The current evidence is not strong enough to say cannabis is effective for improving symptoms of depression or PTSD.

There is an additional complication: people experiencing depression, trauma, anxiety, or other mental health problems may be more likely to use cannabis in the first place. In other words, which came first: the cannabis use or the mental health problem? In many cases, we simply cannot tell from the available research.

Someone with depression who uses cannabis could be experiencing depression because of cannabis, using cannabis because of depression, or experiencing both because of other factors.

This is why researchers distinguish between association and causation.

The biggest mental health concern: psychosis

This is one area where the evidence deserves particular attention.

Cannabis use is associated with an increased risk of psychosis, particularly with frequent use, high-potency THC products, and younger age at initiation. The relationship is especially concerning for people who already have risk factors for psychotic disorders.¹

Psychosis can involve hallucinations, delusions, paranoia, and difficulty distinguishing what is real from what is not.

This does not mean that everyone who uses cannabis will develop psychosis.

It does mean that cannabis is not a neutral substance for everyone.

And potency matters.

Today’s cannabis products can contain substantially more THC than many products available decades ago.¹ So when someone says, “I used marijuana in college and I was fine,” that personal experience may not tell us much about the risks associated with today’s high-potency products.

Can cannabis be addictive?

Yes.

Some people who use cannabis develop cannabis use disorder (CUD).

The CDC reports that approximately 3 in 10 people who use cannabis may have cannabis use disorder, although individual risk varies. Risk is higher among people who begin using during adolescence and people who use cannabis more frequently.⁸

Cannabis use disorder can involve:

Withdrawal is real. People who regularly use cannabis may experience irritability, anxiety, sleep problems, decreased appetite, restlessness, and cravings when they stop.

That does not make cannabis equivalent to every other addictive substance. But it does mean that “You can’t get addicted to cannabis” is not supported by the evidence.

What about the brain and cognition?

Cannabis can affect memory, attention, learning, coordination, reaction time, and decision-making, particularly while someone is intoxicated.¹ These effects have obvious implications for driving, operating machinery, and activities requiring rapid judgment or coordination.

They may also affect problem-solving and the ability to consider alternative perspectives, choices, and behaviors. That matters because these cognitive skills are part of how we evaluate options and choose how to cope with difficult emotions or situations. In other words, it can make choosing healthful or helpful ways of coping more difficult.

Longer-term cognitive effects are more complicated.

Research has found associations between heavier and more frequent cannabis use and cognitive differences. But researchers continue to work through an important question:

How much of the observed difference is caused by cannabis itself, and how much reflects other factors that commonly occur alongside cannabis use?

The safest conclusion is not that cannabis permanently “damages everyone’s brain.” It is that frequent, high-THC cannabis exposure, particularly during adolescence, is not risk-free for the developing brain.

What about the heart and physical health?

This is an area where our knowledge is still developing.

Cannabis can temporarily affect heart rate and blood pressure. Research has also identified associations between cannabis use and cardiovascular events such as heart attack and stroke.¹

However, compared with tobacco, we have much less long-term evidence about the cardiovascular consequences of different patterns and routes of cannabis use.

The route of administration also matters. Smoking cannabis exposes the lungs to combustion products. Edibles eliminate smoke exposure but have a delayed onset, which can make it easier for someone to accidentally take more than intended. Vaping introduces another set of questions about product contents and lung exposure.

So again, “cannabis” is not one exposure.

What about cannabis and exercise?

This is particularly interesting for anyone interested in sports and performance.

Some people report that cannabis makes exercise more enjoyable. It may change how they perceive exertion, reduce boredom, or make movement feel more pleasurable.

But enjoying exercise more is not the same thing as performing better.

There is not strong evidence that THC improves athletic performance. Cannabis can impair reaction time, coordination, attention, and decision-making, which may be particularly problematic in sports requiring speed, precision, balance, or rapid responses.¹

Limited evidence also suggests that cannabis use may interfere with some of the physiological adaptations people are working toward through regular exercise, although this area needs considerably more research.

This is a good example of why the subjective experience of a substance and its objective effect on performance can be different.

You may feel more relaxed, focused, or connected to the experience without actually being faster, stronger, more accurate, or better coordinated.

What about CBD?

CBD deserves its own conversation.

CBD does not produce the same intoxicating “high” as THC, and there are legitimate medical applications for purified CBD.

The CBD market has expanded much faster than the evidence. CBD is marketed for anxiety, sleep, pain, inflammation, recovery, and general wellness. Some of these uses are promising. Many remain unproven.

CBD can also cause side effects and interact with medications. Commercially available products may not contain exactly what their labels suggest.²

So if someone says:

“It’s just CBD.”

That does not necessarily mean there is nothing to consider.

CBD and THC may interact in unexpected ways

There is another misconception worth addressing.

People sometimes assume that CBD will automatically “balance out” or protect against the negative effects of THC.

The evidence is more complicated.

In a randomized clinical trial, researchers found that an oral cannabis preparation containing CBD produced stronger adverse effects than a preparation containing the same amount of delta-9 THC but less CBD. The CBD appeared to inhibit the metabolism of THC, increasing exposure to THC’s active metabolite.⁹

This does not mean that CBD always makes THC effects stronger. The relationship between CBD and THC depends on dose, route, timing, and other factors.

But it does mean that “CBD cancels out THC” is not a scientifically established rule.

What is delta-8 THC?

Delta-8 THC has become increasingly visible in the marketplace.

Chemically, it is closely related to delta-9 THC and can produce intoxicating effects. But the research base is much smaller than the evidence base for delta-9 THC.

The FDA has not evaluated or approved delta-8 THC products for safe use and has received reports of adverse events associated with delta-8 products. The agency has also raised concerns about the manufacturing process because concentrated delta-8 is often produced from CBD through chemical conversion.³

There is another problem:

A product’s label does not necessarily tell you everything that is in the product.

Commercial cannabinoid products can vary in potency and may contain other cannabinoids or contaminants.

This is particularly important for edibles because the effects of THC can take longer to appear. Someone who does not feel anything after taking an edible may assume it “isn’t working” and take more, only to experience a much stronger effect later.

Delta-8 versus delta-9: does “less potent” mean safer?

Not necessarily.

Delta-8 may produce a somewhat different or less intense experience than delta-9 THC, but less intoxicating does not mean non-intoxicating, risk-free, or medically proven.

And because delta-8 products have not undergone the same level of clinical testing as approved medications, we have much less information about their long-term safety and therapeutic value.

The lack of good safety data does not prove that every delta-8 product is harmful. It does mean that we cannot make strong claims about its long-term safety or therapeutic benefits.

This is another place where marketing can move faster than science.

Does occasional use carry the same risk as daily use?

No.

This may be one of the most important takeaways from the research.

Risk is not all-or-nothing.

Frequency, dose, potency, age at first use, route of administration, and individual vulnerability all matter.

Someone who uses a low-dose cannabis product occasionally is not exposed to the same risks as someone using a high-potency THC concentrate every day.

Likewise, someone who starts using cannabis at 15 is not in the same situation as someone who begins occasional use at 45.

This is why broad statements such as “cannabis is safe” or “cannabis is dangerous” don’t tell the whole story.

So, is cannabis good or bad?

Neither.

Cannabis is a psychoactive substance with legitimate medical applications, potential therapeutic benefits, and meaningful risks.

The strongest evidence supports some specific cannabinoid treatments for specific medical conditions, including certain severe seizure disorders and chemotherapy-related nausea and vomiting.

There is also evidence of modest benefit for some people with chronic pain and certain other symptoms.

The evidence is much weaker for using cannabis broadly as a treatment for mental health conditions or general wellness.

The risks become more concerning with higher THC potency, frequent use, younger age of initiation, and individual vulnerability to psychiatric problems.

And we still have important unanswered questions.

We need more research on:

The most important question is, why are you using it?

If you use cannabis, the most useful question may not be:

“Is cannabis good or bad?”

Instead, ask:

Why am I using it? How much am I using? How often? What am I hoping it will do? And what is it actually doing?

If cannabis helps you relax occasionally and does not interfere with your health, relationships, responsibilities, or goals, that is a very different situation from needing cannabis every night to sleep, using it every day to manage emotions, increasing the dose because the old amount no longer works, or continuing to use despite negative consequences.

And if you’re using cannabis to manage anxiety, depression, trauma, pain, sleep, or another health problem, it is worth asking another question:

Is cannabis treating the problem, or helping me temporarily feel less of it?

Those are not always the same thing.

What does the science actually tell us?

The cannabis conversation often gets divided into two camps.

One says:

“Cannabis is medicine.”

The other says:

“Cannabis is dangerous.”

The research doesn’t fit neatly into either statement.

The evidence tells us that some cannabinoids have legitimate medical benefits.

It also tells us that cannabis and THC can produce meaningful physical, psychological, cognitive, and behavioral risks.

And it tells us that those risks and benefits vary considerably depending on what substance or product we’re talking about, how much is used, how often it is used, why it is being used, and who is using it.

Perhaps most importantly, we need to distinguish between:

a promising finding → a clinical trial → an FDA-approved medication → a commercial product → and a personal experience.

Those are not interchangeable forms of evidence.

A person can truthfully say, “Cannabis helps me.”

Another person can truthfully say, “Cannabis makes my anxiety worse.”

A clinical trial can show that purified CBD reduces seizures in a specific population.

And another study can show that high-potency THC is associated with increased risk of psychosis.

All of those things can be true at the same time.

That is the value of looking at the evidence rather than choosing a side.

The goal isn’t to tell you whether cannabis is good or bad.

The goal is to help you make a more informed decision about your health.

---

References and Further Reading

1. National Center for Complementary and Integrative Health (NCCIH). Cannabis (Marijuana) and Cannabinoids: What You Need To Know.

2. Centers for Disease Control and Prevention. About CBD.

3. U.S. Food and Drug Administration. 5 Things to Know About Delta-8 Tetrahydrocannabinol (Delta-8 THC).

4. U.S. Food and Drug Administration. EPIDIOLEX (cannabidiol) oral solution, prescribing information.

5. U.S. Food and Drug Administration. FDA and Cannabis: Research and Drug Approval Process.

6. Agency for Healthcare Research and Quality. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain.

7. Wilson J, et al. The efficacy and safety of cannabinoids for the treatment of mental disorders and substance use disorders: a systematic review and meta-analysis of randomised controlled trials. Lancet Psychiatry. 2026.

8. Centers for Disease Control and Prevention. Understanding Your Risk for Cannabis Use Disorder.

9. Zamarripa CA, et al. Assessment of Orally Administered Δ9-Tetrahydrocannabinol and Cannabidiol: A Randomized Clinical Trial. JAMA Network Open. 2023.

10. Centers for Disease Control and Prevention. Cannabis Health Effects.

A note about the evidence

Cannabis research is challenging because studies often involve different products, THC concentrations, doses, routes of administration, and populations. Much of the research is observational rather than randomized, which makes cause and effect difficult to establish.

That is why this article distinguishes between what is well established, what is promising, what is associated with risk, and what remains uncertain.

This article is for educational purposes and is not a substitute for individualized medical or psychological advice.

If you would like to discuss your personal experience with me, or any other topics for psychotherapy, please reach out! I offer free 15-minute virtual consultations, and see folks in person in Charleston, SC and around the USA in PSYPACT states (up to 43 active states: https://psypact.gov/page/psypactmap). Schedule now (consult, first or return appointment)!

Today prepares you for tomorrow. Anything of value requires ongoing, consistent effort.
– Eva Serber, PhD, LLC

• Facebook
• Twitter
• LinkedIn
• Pinterest
• Mail